Literature DB >> 20861096

Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat.

J Benito1, D Aguado, M B Abreu, J García-Fernández, I A Gómez de Segura.   

Abstract

BACKGROUND: Intraoperative opioids reduce anaesthetic requirements and thus limit the side-effects derived from high doses of the latter. Cyclooxygenase (COX) inhibitors can also be given but it remains unclear whether they further reduce the anaesthetic requirements. Our aim was to determine whether COX inhibitors potentiate the effect of remifentanil on the minimum alveolar concentration (MAC) of sevoflurane anaesthetized rats.
METHODS: Male Wistar rats received remifentanil under sevoflurane anaesthesia, and the MAC was determined before and at two time intervals after, separated by 1.5 h. Rats were randomly allocated to receive paracetamol, metamizole, ketoprofen, or parecoxib just before one of the two studied time intervals. The MAC was determined from alveolar gas samples at the time of tail clamp. Data were analysed with an analysis of variance for repeated measures.
RESULTS: Paracetamol potentiated the MAC reduction produced by remifentanil in rats (P=0.002), whereas metamizole, ketoprofen, and parecoxib failed to produce such an effect. Furthermore, paracetamol and remifentanil produced a maximum degree of MAC reduction [35 (10)%] even when a tolerance effect to remifentanil was observed in animals given remifentanil alone (P<0.001). A tolerance to remifentanil was not observed when metamizole, ketoprofen, or parecoxib was given once the opioid infusion has been started (P>0.05).
CONCLUSIONS: COX inhibitors differentially potentiate the analgesic effect produced by remifentanil on the sevoflurane MAC, and paracetamol was the most effective drug. However, since all COX inhibitors prevented a tolerance effect to opioids once it was established, intraoperative rather than preoperative administration of these drugs is suggested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861096     DOI: 10.1093/bja/aeq241

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  Determination of minimum alveolar concentration for isoflurane and sevoflurane in a rodent model of human metabolic syndrome.

Authors:  Dinesh Pal; Meredith E Walton; William J Lipinski; Lauren G Koch; Ralph Lydic; Steve L Britton; George A Mashour
Journal:  Anesth Analg       Date:  2011-12-13       Impact factor: 5.108

Review 2.  Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review.

Authors:  Sang Hun Kim; Nicoleta Stoicea; Suren Soghomonyan; Sergio D Bergese
Journal:  Front Pharmacol       Date:  2014-05-08       Impact factor: 5.810

3.  No evidence for the development of acute analgesic tolerance during and hyperalgesia after prolonged remifentanil administration in mice.

Authors:  Hideaki Ishii; Andrey B Petrenko; Tatsuro Kohno; Hiroshi Baba
Journal:  Mol Pain       Date:  2013-03-07       Impact factor: 3.395

4.  Effect of Acetaminophen Alone and in Combination with Morphine and Tramadol on the Minimum Alveolar Concentration of Isoflurane in Rats.

Authors:  Julio R Chavez; José A Ibancovichi; Pedro Sanchez-Aparicio; Carlos M Acevedo-Arcique; Rafael Moran-Muñoz; Sergio Recillas-Morales
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.